BioAge Labs (BIOA) Free Cash Flow (2023 - 2026)

BioAge Labs has disclosed Free Cash Flow across 4 years of filings, most recently posting -$19.6 million for Q2 2026.

• In Q2 2026, Free Cash Flow rose 2.68% year-over-year to -$19.6 million; the TTM figure through Jun 2026 stood at -$88.1 million (down 51.05% YoY), while the FY2025 annual figure was -$82.3 million, down 58.7% from the prior year.
• Free Cash Flow came in at -$19.6 million for Q2 2026 at BioAge Labs, up from -$24.1 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$5.2 million in Q4 2024 to a low of -$28.4 million in Q4 2025.
• Average Free Cash Flow over 4 years is -$16.9 million, with a median of -$16.1 million recorded in 2025.
• Year-over-year, Free Cash Flow surged 39.27% in 2024 and tumbled 449.24% in 2025.
• Over 4 years, Free Cash Flow stood at -$8.5 million in 2023, then surged by 39.27% to -$5.2 million in 2024, then plunged by 449.24% to -$28.4 million in 2025, then jumped by 30.94% to -$19.6 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$19.6 million in Q2 2026, -$24.1 million in Q1 2026, and -$28.4 million in Q4 2025.